Rigel Pharmaceuticals Balance Sheet (2010-2025) | RIGL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	20.05M	84.82M	30.40M	18.89M	24.68M	27.20M	29.87M	24.46M	40.28M	48.81M	45.41M	32.79M	25.57M	36.05M	51.69M	56.75M	45.73M	53.41M	48.53M	40.58M
Short-term Investments (Quarter)	19.30M	68.56M	112.74M	106.08M	82.84M	61.97M	51.78M	33.75M	18.38M	15.54M	16.94M	24.15M	23.98M	13.05M	9.42M	20.57M	31.37M	54.97M	88.61M	114.38M
Cash & Current Investments (Quarter)	39.34M	153.39M	143.15M	124.97M	107.52M	89.17M	81.64M	58.21M	58.66M	64.36M	62.35M	56.93M	49.55M	49.10M	61.11M	77.32M	77.10M	108.38M	137.14M	154.96M
Receivables - Net (Quarter)	142.19M	17.37M	14.99M	15.47M	15.24M	17.20M	15.53M	20.00M	29.37M	20.82M	23.55M	30.55M	27.51M	28.90M	30.57M	41.62M	3.00M	39.91M	45.92M	51.76M
Receivables - Other (Quarter)																	0.06M	0.06M	0.06M
Receivables (Quarter)	142.19M	17.37M	14.99M	15.47M	15.24M	17.20M	15.53M	20.00M	29.37M	20.82M	23.55M	30.55M	27.51M	28.90M	30.57M	41.62M	3.06M	39.96M	45.98M	51.76M
Raw Materials (Quarter)		5.14M	5.14M	5.14M	4.55M	4.55M	4.55M	4.55M	6.91M	6.88M		4.61M	3.92M	2.15M	1.57M	1.08M	1.08M	9.63M	6.95M
Work In Process (Quarter)	0.84M	0.34M	0.48M	0.16M	1.04M	0.57M	1.24M	2.66M	2.05M	2.05M		1.88M	5.12M	6.01M	1.81M	1.23M	1.11M	2.03M	5.49M
Finished Goods (Quarter)	0.96M	1.35M	1.41M	1.31M	1.17M	1.09M	1.32M	1.90M	2.12M	1.86M		1.51M	1.27M	4.37M	5.83M	5.01M	3.76M	2.71M	1.79M
Inventory (Quarter)	6.95M	6.83M	7.04M	6.62M	6.76M	6.22M	7.12M	9.12M	11.08M	10.78M	6.11M	5.52M	6.58M	8.06M	4.78M	6.00M	4.66M	10.42M	13.30M	11.51M
Prepaid Assets (Quarter)	8.27M	6.61M	5.93M	7.41M	9.41M	7.94M	6.16M	8.26M	7.87M	4.97M	3.02M	6.26M	8.85M	8.66M	9.99M	4.52M	23.26M	16.68M	5.86M	21.94M
Current Assets (Quarter)	196.76M	184.20M	171.10M	154.47M	138.94M	120.52M	110.44M	115.90M	106.97M	100.92M	95.02M	99.27M	92.49M	94.72M	106.47M	135.10M	146.56M	175.39M	214.93M	240.17M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	2.50M	2.67M	2.65M	2.18M	2.14M	1.83M	1.69M	0.86M	0.29M	0.21M	0.19M	0.17M	0.14M	0.12M	0.10M	0.09M	0.08M	0.06M	0.05M
Goodwill & Intangibles (Quarter)								15.00M	14.68M	14.41M	14.15M	13.88M	28.86M	28.27M	27.69M	27.10M	26.51M	25.92M	25.34M	24.75M
Long-Term Deferred Tax (Quarter)																				245.85M
Other Non-Current Assets (Quarter)	0.82M	0.84M	0.94M	0.97M	0.46M	0.40M	0.48M	0.64M	0.54M	0.54M	4.96M	3.06M	4.32M	4.74M	4.76M	1.53M	1.52M	4.18M	1.17M	1.91M
Non-Current Assets (Quarter)	19.23M	17.40M	15.41M	12.86M	10.14M	7.48M	5.17M	18.38M	16.64M	16.17M	20.30M	17.96M	34.03M	33.69M	32.95M	28.87M	29.41M	31.34M	27.61M	273.43M
Assets (Quarter)	215.99M	201.60M	186.52M	167.33M	149.07M	128.00M	115.61M	134.28M	123.61M	117.09M	115.32M	117.22M	126.52M	128.41M	139.42M	163.98M	175.97M	206.74M	242.53M	513.59M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	5.09M	1.69M	3.14M	3.79M	4.61M	2.15M	2.72M	15.00M	6.29M	5.24M	8.00M	7.14M	9.28M	6.13M	3.81M	3.34M	3.95M	7.29M	3.85M	7.19M
Payables (Quarter)	5.09M	1.69M	3.14M	3.79M	4.61M	2.15M	2.72M	15.00M	6.29M	5.24M	8.00M	7.14M	9.28M	6.13M	3.81M	3.34M	3.95M	7.29M	3.85M	7.19M
Accumulated Expenses (Quarter)	6.59M	7.76M	9.46M	10.69M	6.63M	7.53M	8.77M	8.87M	5.66M	6.74M	8.09M	8.68M	5.25M	6.37M	7.92M	10.14M	6.02M	7.90M	10.06M	11.91M
Other Accumulated Expenses (Quarter)	5.47M	16.23M	13.49M	13.51M	16.50M	11.82M	17.60M	5.00M	5.10M	5.01M	5.03M	5.33M	1.00M	5.93M	9.97M	11.75M	7.44M	8.59M	8.94M	11.47M
Short term Debt (Quarter)												7.23M	14.78M			7.27M	14.81M	22.36M	29.76M	29.81M
Current Leases (Quarter)	8.92M	9.22M	9.57M	9.89M	8.30M	5.81M	3.31M	1.13M	0.45M	0.47M	0.67M	0.69M	0.71M	0.64M	0.47M	0.28M	0.46M	0.52M	0.59M	0.61M
Current Deferred Revenue (Quarter)	9.50M	5.81M	3.16M	2.60M	2.10M	1.54M	1.37M	1.37M	1.37M	1.35M	1.35M	1.35M	1.35M	1.35M	1.35M	1.35M	1.35M	1.35M	1.35M
Total Current Liabilities (Quarter)	52.02M	59.54M	59.28M	63.55M	59.23M	54.95M	47.27M	65.21M	45.52M	44.02M	48.27M	53.27M	73.20M	58.65M	54.31M	63.30M	66.63M	86.64M	94.40M	99.24M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)	19.84M	19.86M	19.89M	19.91M	29.85M	29.84M	39.47M	39.45M	59.48M	59.57M	59.66M	52.37M	44.91M	59.69M	59.76M	59.68M	44.93M	37.45M	29.97M	52.29M
Non-Current Deffered Revenue (Quarter)
Operating Leases (Quarter)	17.20M	5.85M	3.31M	0.76M	8.30M			0.97M	0.80M	0.63M	0.47M	0.28M	0.10M				0.86M	0.71M	0.56M	0.40M
Other Non-Current Liabilities (Quarter)	57.53M	48.23M	54.37M	52.73M	53.20M	46.89M	48.71M	42.26M	42.06M	40.98M	38.76M	39.94M	39.98M	39.98M	39.98M	5.00M	5.00M
Total Non-Current Liabilities (Quarter)	80.16M	85.26M	82.48M	84.23M	89.07M	84.79M	86.73M	105.63M	105.80M	104.22M	108.40M	105.92M	118.21M	118.34M	114.07M	155.69M	152.41M			122.11M
Total Liabilities (Quarter)	137.69M	133.49M	136.85M	136.95M	142.28M	131.68M	135.44M	147.90M	147.87M	145.21M	147.16M	145.87M	158.19M	158.32M	154.06M	160.69M	157.41M	124.80M	124.92M	122.11M
Shareholder's Equity
Total Debt (Quarter)	19.84M	19.86M	19.89M	19.91M	29.85M	29.84M	39.47M	39.45M	59.48M	59.57M	59.66M	59.60M	59.69M	59.69M	59.76M	66.95M	59.75M	59.81M	59.73M	82.11M
Common Equity (Quarter)	78.30M	68.11M	49.67M	30.37M	6.80M	-3.68M	-19.83M	-13.62M	-24.26M	-28.11M	-31.83M	-28.64M	-31.67M	-29.91M	-14.64M	3.29M	18.57M	81.93M	117.61M	391.48M
Shareholder's Equity (Quarter)	78.30M	68.11M	49.67M	30.37M	6.80M	-3.68M	-19.83M	-13.62M	-24.26M	-28.11M	-31.83M	-28.64M	-31.67M	-29.91M	-14.64M	3.29M	18.57M	81.93M	117.61M	391.48M
Liabilities and Shareholders Equity (Quarter)	215.99M	201.60M	186.52M	167.33M	149.07M	128.00M	115.61M	134.28M	123.61M	117.09M	115.32M	117.22M	126.52M	128.41M	139.42M	163.98M	175.97M	206.74M	242.53M	513.59M
Retained Earnings (Quarter)	-0.00M	0.01M	-1301.24M	-1323.89M	-1351.33M	-1364.82M	-1383.86M	-0.15M	-1395.99M	-1402.60M	-0.01M	0.01M	-0.01M	-0.01M	-1404.41M	-1390.07M	-1378.62M	0.01M	0.10M	-1023.04M
Treasury Shares (Quarter)				0.23M	1.21M	1.19M	1.17M	1.10M	1.99M	1.96M	1.94M	0.19M	4.07M	0.39M	0.38M	0.39M	0.57M	0.57M	0.57M	0.61M

Research Tools

Rigel Pharmaceuticals Balance Sheet (2010-2025) | RIGL

Create an account

Sign In

Reset Password